Set as Homepage - Bookmark This Page   
You are here:Home >Careers & Partnerships >Waters... noitazilaicremmoC dna tnempole Content

Waters... noitazilaicremmoC dna tnempole

Source: Editor: Careers & PartnershipsDate: 2025-05-21 21:38:32
Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists

1.3182s , 6836.7734375 kb

Copyright © 2025 Powered by Waters... noitazilaicremmoC dna tnempole,  

sitemap

Top